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Abstract

Candida albicans is a commensal fungus, normally living with its human host, however, it has
the ability to cause invasive infection. Candida albicans is the fourth most frequent nosocomial
infection affecting a vulnerable immunocompromised population. Candida albicans exhibits
different morphologies including yeast, pseudohyphae, and hyphae. The varying morphological
potential of this organism is a virulence trait. Because of this, research has focused on what
drives activation of hyphal formation as well as what impedes it. During a filamentation assay, a
novel observation pertaining to a subgroup of proteins being downregulated early after
germination, was made. In this study, we constructed an over-expression strain of one of these
proteins and have used known hypha inducing media to determine if it will have an impact on
filamentation. With the conditions tested thus far, no significant impacts on morphology have
been observed.
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1

Candida albicans is a commensal fungus, normally colonizing the gastrointestinal tract and other

2

mucosal membranes of its human host. Yet, Candida has virulence potential associated with different

3

environmental cues affecting signal transduction pathways, making Candida an opportunistic

4

pathogen as well. Changes in host immunity and complex environmental factors play a large role in

5

C. albicans transformation from commensal to pathogen. Candida is able to change its phenotypic

6

state between a single celled yeast to filamentous, hyphal or pseudohyphal, morphologies under

7

varying circumstances. There are superficial types of Candida infections. Such infections are

8

prevalent in AIDS patients whom frequently suffer from oropharyngeal infections known as oral

9

thrush (1–3). Or, it is also known that 75% of women will suffer some form of Candida related

10

vulvogenital infection at least once in their lifetime, impacting their quality of life (4). Candida

11

albicans is a top cause of nosocomial infections worldwide (5). In fact, there are about 400,000

12

bloodstream infections worldwide with a 46-75% mortality rate and 10,000 deaths in the United

13

States alone, all attributed to a more severe form of Candida bloodstream infection (Reviewed in (6)).

14

The high mortality rate of this organism makes understanding the associated virulence mechanisms

15

paramount.

16

Aside from the high mortality rate, the associated prevalence of Candida infections is important. A

17

reason for rise in fungal infections can be associated with the growing immunocompromised

18

populations in a hospital setting, a side effect of the medical advancements granting an increased

19

volume of patients with hospital stays. Those advancements include organ transplantation, stem cell

20

transplantation, cancer therapies such as chemotherapy, premature infant deliveries and care, and

21

implanted medical devices (7). These medical treatments compromise the immunity of patients by

22

some degree enabling Candida bloodstream infections. Treatment difficulties have arisen as drug

23

resistance has occurred in virulent strains of candida (8). Treatment difficulties are also exacerbated
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24

by the lack of efficacy in detecting techniques from cultured based diagnostic tests typically used in

25

detecting fungal infections; it is reported that about 50% of invasive candidiasis cases were missed

26

by this way of detection (9).

27

C. albicans has developed strategies in order to survive in different niches of a human host and cause

28

disease. A highlight here would be the ability of this organism to undergo morphological switching

29

under varying circumstances (10). Although the importance of morphological switching as a

30

virulence trait was accepted, there wasn’t a manner of testing whether or not this theory was ‘true’ in

31

experimental studies until a group constructed a strain that could be regulated between yeast and

32

filamentous growth form (11). This study was the first time ever where the theory of morphological

33

switching being necessary for virulence, was proven evident. Morphology becomes important during

34

biofilm formation, another virulence trait of C. albicans. Biofilms are formed when yeast cells adhere

35

to a surface, commonly medical implanted devices like heart valves or pacemakers, followed by

36

hyphal morphogenesis, and eventually the film forms in a population of filamentous and yeast cells

37

which produce polysaccharides, proteins and nucleic acids (12–14). When biofilms form, they have

38

the potential of impairing the function of the devices they form on, having the correct surface to

39

adhere to, as well as maintaining the ability to sustain infection. (15).

40

Environmental factors responsible for activation of Candida albicans hyphal growth include:

41

presence of serum, neutral pH, 5% CO2, and low nitrogen (10, 14, 16, 17). These environmental cues

42

activate important pathways such as the mitogen activated protein kinase (MAPK), cyclic adenosine

43

monophosphate (cAMP), calcineurin, and HOG pathways (10, 18). However, activation of hyphal

44

growth must be accompanied by downregulation of filament repressors, such as Nrg1 (14, 19).

45

Previous work in the lab identified a group of proteins that were seen to be degraded early during

46

filamentation when induced in 37°C, a known activation factor of hyphal formation. This finding
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47

presented the question if the presence of these proteins was necessary for morphogenesis from yeast

48

form to filamentous growth, as well as what their true function is. The focus of this study is one of

49

these proteins. However, this protein remains uncharacterized and is called C1_05590_C. The

50

primary way of analyzing this protein was by increasing its expression levels followed by testing

51

over-expression strains under the influence of known filamentation activating cues. This allowed for

52

the determination of whether or not this protein influences the transition from yeast to filamentous

53

growth. Furthermore, the importance of deciphering events of morphological switching involves the

54

better understanding of this phenomenon to drive clinical applications directed in reducing the high

55

mortality rates associated with Candida infections.

56
57

RESULTS AND DISCUSSION

58
59

Wild-type strain SC5314 was used as a control and was grown along sa-C1_05590_C mutants

60

from the same cell line. There were no significant differences between the two mutant strains and

61

the wild-type strain when grown in different liquid media. When grown in yeast conditions (28

62

°C) in liquid YPD, all cells remained in yeast form. When grown in filamentous inducing

63

conditions corresponding to YPD, GLcNAc, YNB, RPMI, and Spider media, filamentation was

64

clearly observed amongst all streaked colonies examined. This is reflective of the growth

65

conditions of the mutants not being affecting differently in any significant pathways involved in

66

the morphological switching from yeast to filamentous growth form than the wild type strain.

67
68

When strains were grown on solid media under filamentous growth conditions, again, filamentous

69

growth was observed in all strains. For example, a distinct crenulation on spider media is a typical

4

70

macroscopic outcome of SC5314 and this was maintained in the mutant strains macroscopic

71

analysis. Invasion into the media was also apparent amongst all strains examined as washing of

72

the cells demonstrated this, indicating again, no impact on filamentous growth form observed in

73

the mutant strains tested. Lee’s medium contains a variety of amino acids necessary for induction

74

of filamentous growth from yeast form growth. Similarly, Spider medium is known to induce

75

filamentous growth based on carbon availability. Lastly, GlcNAc is known to stimulate activating

76

pathways of hyphae inducing outcomes, such as activating the cAMP signaling pathway.

77
78

METHODS AND MATERIALS

79
80

Entailed in this study was the construction of a Candida albicans vector in order to insert, clone,

81

and express proteins of interest to analyze their effect under conditions where filamentous growth

82

is known to be activated. These constructs were made up of CIpSAT-SA, the CIp component being

83

a modified version of the CIp10 vector, created specifically for Candida integration. The SAT

84

component was introduced to CIp10, encoding a nourseothricin resistance and replacing the URA

85

component of CIp10. Finally, the SA component of CIpSAT-SA is the shorter of the two Actin

86

promoters, which are constitutively on, ensuring the maintenance of elevated levels of

87

C1_05590_C in mutant strains.

88
89

However, the protein of interest was first designed into a pMiniT which does not integrate well

90

into Candida cells. Xho1 and Mlu1 enzymes allowed for a sub-cloning of C1_05590_C from a

91

pMiniT vector into a CIpSAT-SA construct. Once the final transformation was done, the remainder

5

92

of the experiment involved culture assays as the primary way of attempting to characterize the role

93

and function of this novel protein.

94
95

Strains and Growth Conditions

96
97

C. albicans strain SC5314 and mutant strains sa-C1_05590_C were grown on yeast-peptone-

98

dextrose (YPD) agar in 28 °C. The mutant strain was engineered as follows: 5’-Xho1-AUG-His6-

99

C1_05590_C-Myc-TAA-Mlu1-3’ in a pMiniT plasmid. The candida plasmid CIp10 was

100

reengineered to replace the URA component with a SAT component encoding nourseothricin

101

resistance for selectivity, as well as incorporating the short act promoter (SA) allowing for

102

constitutive production of the protein of interest. The name of this new construct is CIpSAT-sa,

103

maintaining a Xho-1 and Mlu-1 cutsite. The enzymes Xho-1 and Mlu-1 were used to cut out the

104

designed protein from pMiniT and to linearize CIpSAT-sa. The insert and linearized CIpSAT-sa

105

were ligated, followed by a Stu-1 digestion to prepare the DNA for an electroporation

106

transformation into SC5314 cells (20, 21). To ensure the insert integrated into CIpSAT-sa, a

107

double digestion using Xho-1 and Mlu-1 was done and the DNA lengths of the insert-C1_05590_C

108

and CIpSAT-sa empty plasmid were compared using gel electrophoresis. After transformation by

109

electroporation was performed, the plated colonies were picked and patched onto another plate.

110

This allowed for colonyPCR followed by gel electrophoresis to confirm that the correct product

111

was growing on the patched plate. Once gel electrophoresis on the double digested DNA and

112

colonyPCR confirmed the correct transformant was present, a YPD plate was streaked with two

113

transformants and a WT strain.

114
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115

Filamentation Assay

116
117

Two approaches were taken for filamentation assays. One approach was by done by streaking YPD

118

grown strains onto plates of YPD, YPD+Serum, Spider, and SLAD. All but SLAD were placed in

119

37 °C to induce filamentation. SLAD was placed in 28 °C. A second approach involved liquid

120

media. A 1mL aliquot was taken, washed twice with water, and resuspended in water to dilute

121

(1:20) into fresh media including YPD, Spider, Lee’s, GLcNAc, RPMI, and YNB with shaking at

122

37 °C for three hours. Following, microscopy was used to visualize the cells for phenotypic

123

comparison.
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September 6, 2019
David Martin, PhD
230 Mary Idema Pew Library
1 Campus Drive
Allendale, Michigan 49401
Dear Dr. David Martin,
I will soon have a Bachelor of Science in Biochemistry from Grand Valley State
University and I am currently a Ronald E. McNair Scholar at this institution. My regard for the
sciences has led me to investigate a component of the organism Candida albicans in the
Thomas-Cleary Lab, an established laboratory in the biomedical sciences department. Under
their direction I have used a microbiological approach in uncovering some research questions
regarding an uncharacterized protein in the organism.
In my research I used a microbiological approach to examine the impact of the
uncharacterized protein, C1_05590_C, on filamentation. Morphogenesis is an important
virulence trait of C.albicans. This fungal microorganism lives as a commensal in most of the
human population, however, is a known opportunistic pathogen. As a pathogen, Candida is a top
nosocomial infection, impacting already vulnerable populations. In my recent unpublished
article, Analyzing the Role of a Protein Downregulated After Induction of Filamentous Growth in
Candida Albicans, I explain how I conducted this research. This paper entails two focuses: One
questioning what this proteins impact is during morphological switching in Candida, and two,
my attempt to uncover what this proteins function in the organism is. To do this, I overexpressed
the protein by placing it in a vector with a constitutive promoter, allowing for constitutive
production of it. This was followed by testing the constitutive mutant under conditions known to
induce filamentation.
Infection and Immunity is a journal within the American Society of Microbiology and is
fitting for my article because Candida is known to cause a deep-seated infection. My article
focuses on a novel protein possibly associated with an important virulence trait of Candida
infections. The impact of this protein remains enigmatic as it has not been observed to evade
morphological switching with the media it has been analyzed with. Its function also remains a
mystery as the mutant has not been observed to function differently than the wild-type strain.
The research I have conducted will bring attention to this uncharacterized protein, for others to
continue understanding the underlying mechanisms intrinsic to the virulence trait of phenotypic
switching. I have contributed to a starting point, where someone else who is intrigued, can carry
on. The only other known information about this novel gene is given by computational
predictions.
Thank you,
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Jazmine Vasquez
McNair Scholar
Biochemistry Student
Grand Valley State University
616-589-7842
vasqueja@mail.gvsu.edu

Target publication
American Society for Microbiology - Infection and Immunity
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